Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome

Visualitza/ Obre
Data de publicació
2017Autor/a
Pradas Barriga, Irene
Rovira-Llopis, Susana
Bañuls, Celia
Rocha, Milagros
Hernández-Mijares, Antonio
Victor, Victor M.
Citació recomanada
Jové Font, Mariona;
Pradas Barriga, Irene;
Naudí i Farré, Alba;
Rovira-Llopis, Susana;
Bañuls, Celia;
Rocha, Milagros;
...
Pamplona Gras, Reinald.
(2017)
.
Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome.
Oncotarget, 2017, vol. 9, núm. 4, p. 4522-4536.
https://doi.org/10.18632/oncotarget.23393.
Metadades
Mostra el registre d'unitat completResum
Purpose: In this work, a non-targeted approach was used to unravel changes in the plasma lipidome of PCOS patients. The aim is to offer new insights in PCOS patients strictly selected in order to avoid confounding factors such as dyslipemia, obesity, altered glucose/insulin metabolism, cardiovascular disease, or cancer.
Results: Multivariate statistics revealed a specific lipidomic signature for PCOS patients without associated pathologies. This signature implies changes, mainly by down-regulation, in glycerolipid, glycerophospholipid and sphingolipid metabolism suggesting an altered biosynthetic pathway of glycerophospholipids and cell signaling as second messengers in women with PCOS.
Conclusions: Our study confirms that a lipidomic approach discriminates a specific phenotype from PCOS women without associated pathologies from healthy controls.
Methods: In a cross-sectional pilot study, data were obtained from 34 subjects, allocated to one of two groups: a) lean, healthy controls (n = 20), b) PCOS patients (n = 14) with diagnosis based on hyperandrogenaemia, oligo-anovulation and abnormal ovaries with small follicular cysts. A detailed biochemical characterization was made and lipidomic profiling was performed via an untargeted approach using LC-ESI-QTOF MS/MS.
És part de
Oncotarget, 2017, vol. 9, núm. 4, p. 4522-4536Projectes de recerca europeus
Col·leccions
Els fitxers de llicència següents estan associats amb aquest element:
Publicacions relacionades
Mostrant elements relacionats per títol, autor i matèria.
-
Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women
Pradas Barriga, Irene; Rovira-Llopis, Susana; Naudí i Farré, Alba; Bañuls, Celia; Rocha, Milagros; Hernandez-Mijares, Antonio; Pamplona Gras, Reinald; Victor, Victor M.; Jové Font, Mariona (Nature Publishing Group, 2019-11-05)Metformin is one of the treatments used for pcoS pathology decreasing body weight, plasma androgen, FSH and glucose levels. Unfortunately, there is little known about metformin’s effects on lipid metabolism, a crucial ... -
Lipidomics Reveals a Tissue-Specific Fingerprint
Pradas Barriga, Irene; Huynh, Kevin; Cabré Cucó, Rosanna; Ayala Jové, Ma. Victoria (Maria Victoria); Meikle, Peter J.; Jové Font, Mariona; Pamplona Gras, Reinald (Frontiers Media, 2018)In biological systems lipids generate membranes and have a key role in cell signaling and energy storage. Therefore, there is a wide diversity of molecular lipid expressed at the compositional level in cell membranes and ... -
Caloric restriction reveals a lipidomic and metabolomic signature in liver of male mice
Jové Font, Mariona; Naudí i Farré, Alba; Ramírez-Núñez, Omar; Portero Otín, Manuel; Selman, Colin; Withers, Dominic J.; Pamplona Gras, Reinald (John Wiley & SonsAnatomical Society, 2014-10-01)Lipid composition, particularly membrane unsaturation, has been proposed as being a lifespan determinant, but it is currently unknown whether caloric restriction (CR), an accepted life-extending intervention, affects ...